サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1758046

血液粘度計の世界市場

Blood Viscometers

出版日
ページ情報
英文 275 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
血液粘度計の世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 275 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血液粘度計の世界市場は2030年までに46億米ドルに達する

2024年に34億米ドルと推定される血液粘度計の世界市場は、2024年から2030年にかけてCAGR 4.9%で成長し、2030年には46億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである回転式粘度計製品は、CAGR 4.0％を記録し、分析期間終了までに30億米ドルに達すると予測されます。キャピラリ粘度計製品セグメントの成長率は、分析期間中CAGR 6.8％と推定されます。

米国市場は9億3,860万米ドル、中国はCAGR 7.7％で成長予測

米国の血液粘度計市場は、2024年に9億3,860万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.7%として、2030年までに9億110万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4%と4.9%と予測されています。欧州では、ドイツがCAGR 3.1%で成長すると予測されています。

世界の血液粘度計市場- 主要動向と促進要因のまとめ

血液粘度計が心血管および血液学的評価において臨床的重要性を増している理由とは？

血液粘度計は、心血管、代謝、血液疾患の診断や管理における重要なバイオマーカーとして、血液粘度の重要性を認識する医療関係者の増加に伴い、臨床的な関連性が高まっています。血液粘度、すなわち血液の厚さと粘着性は、血管抵抗と全体的な循環効率を決定する上で重要な役割を果たしています。血液粘度の上昇は、高血圧、アテローム性動脈硬化症、糖尿病、脳卒中、末梢動脈疾患など、さまざまな疾患と関連しています。そのため、臨床医は、特に高齢者、糖尿病患者、慢性炎症性疾患患者などのハイリスク集団の日常診断やリスク層別化プロトコールに粘度測定を組み込んでいます。コレステロール値、血圧値、グルコース値だけに注目しがちな従来の診断法とは異なり、粘度計は様々なせん断速度下での血液の力学的挙動を把握し、血管の健康状態をより総合的に把握することができます。これらの測定は、主要な心血管イベントの前に起こりうる微小循環機能障害や内皮ストレスを理解する上で特に価値があります。個別化医療と予防医療が勢いを増すにつれ、血液粘度計のような正確なポイント・オブ・ケア・ツールの必要性が高まっています。病院、調査機関、専門クリニックでは、診断モデルを改良し、治療計画を最適化するために、このような機器を採用するケースが増えています。このような進化を遂げる医療現場において、血液粘度計は単なる検査機器としてではなく、精密な心臓血管治療を可能にする重要なツールとして台頭してきています。

技術革新は血液粘度計の精度とアクセシビリティをどのように向上させていますか？

粘度計技術の進歩は、これらの機器を非常に洗練された使いやすい診断ツールへと変貌させ、臨床および研究用途の両方において、より利用しやすくしています。従来の粘度計は、より大量の血液を必要とし、複雑な校正や手動操作が必要であったため、専門的なラボ以外での普及は限られていました。今日の血液粘度計には、マイクロ流体システム、デジタルセンサー、自動分析ソフトウェアが組み込まれており、使いやすさ、スピード、精度が大幅に向上しています。多くの最新モデルは、1滴の血液で複数のせん断速度測定を行うことができ、リアルタイムで詳細なレオロジープロファイルを提供します。熱的・機械的安定化の革新により測定結果の再現性が向上し、タッチスクリーンインターフェースとワイヤレス接続により使いやすさとデータ統合性が向上しました。これらの技術向上により、電子カルテ（EMR）とのシームレスな接続が可能になり、臨床医は慢性疾患管理の一環として血液粘度の経時変化をモニターできるようになりました。さらに、ベッドサイドでの診断、救急医療、移動医療ユニット用に小型化されたポータブル粘度計が開発されており、分散型環境での応用範囲が広がっています。人工知能と機械学習も役割を果たし始めており、複雑な粘度パターンを解釈できるアルゴリズムが早期診断と予測分析をサポートしています。費用対効果に優れ、拡張性の高いソリューションが続々と登場する中、技術革新は血液粘度計を診断検査の周辺から主流の臨床ワークフローへと押し上げ、その有用性を拡大するヘルスケア環境の幅を広げています。

多様な臨床アプリケーションは、血液粘度計の市場機会をどのように拡大していますか？

血液粘度計の幅広い医療分野での汎用性は、市場の可能性を大きく広げています。心臓病学では、血行動態ストレスや血栓リスクの評価に使用され、抗凝固剤やスタチンの使用に役立つ重要なデータを提供します。内分泌学では、血液粘度測定が糖尿病やメタボリックシンドローム患者の微小血管合併症の評価に役立っています。がん専門医は、多発性骨髄腫などの特定の血液悪性腫瘍患者にみられる粘性亢進症候群のモニタリングに粘度測定データを使用しています。神経内科では、血液粘度は、特に高齢者集団における脳卒中リスクや認知機能の低下を評価する可能性を示しています。血液専門医は、多血症、貧血、血液凝固障害の診断とモニターにこれらの装置を利用しています。さらに、研究者たちは、炎症性疾患、自己免疫疾患、さらには高凝固性が重篤な合併症として浮上しているCOVID-19のような感染症における血液粘性の役割を調査しています。製薬会社も臨床試験で血液粘度計を使用し、特に血管系を標的とする治験薬のレオロジー効果を評価しています。このような幅広い用途が、病院、診断ラボ、学術機関、バイオテクノロジー企業での需要を促進しています。さらに、スポーツ医学やウェルネス・センターでは、エリート・アスリートのパフォーマンス・モニタリングや心血管スクリーニングのために粘度計が採用され始めています。血液粘度が重要な健康指標であるという認識が高まるにつれ、多職種によるケアモデルへの組み込みが急速に拡大し、メーカーとヘルスケアプロバイダー双方に新たな成長の道が開けています。

血液粘度計市場の成長促進要因は？

血液粘度計市場の成長は、現代ヘルスケアの優先事項の移り変わりを反映した、医療、技術、経済、人口統計学的要因の合流によってもたらされます。主な要因のひとつは、心血管疾患と代謝性疾患の世界の負担の増加であり、そのため臨床医は標準的なマーカーだけでなく、より微妙な診断ツールを求めるようになっています。先進経済諸国でも新興経済諸国でも生活習慣病が蔓延するにつれ、血管の健康状態を予測できる早期発見ツールの需要が高まっています。技術革新により、これらの機器はより小型で手頃な価格となり、使いやすくなったため、小規模な診療所や分散化した医療環境での導入が容易になりました。ヘルスケアシステムは、予防医療と価値に基づくアウトカムを優先する傾向が強まっており、血液粘度計の早期診断能力と一致しています。包括的な心血管リスク評価を強調する規制当局の支援や臨床ガイドラインの更新は、診療における血液粘度計の役割をさらに正当化しています。これと並行して、特にアジア太平洋とラテンアメリカにおける医学研究と診断インフラへの投資が増加し、新市場が開拓され、世界な展開が拡大しています。教育イニシアチブと継続的医学教育（CME）プログラムは、臨床医が血液粘度の重要性と粘度データの解釈方法を理解するのに役立ち、使用率と信頼性を高めています。最後に、粘度計とデジタルヘルス・プラットフォームやデータ解析ツールとの統合により、患者の長期モニタリングや慢性疾患管理における粘度計の有用性が高まっています。これらの促進要因が相まって、血液粘度計市場は臨床と商業の両領域で持続的に拡大するための強固な基盤が築かれつつあります。

セグメント

製品（回転式粘度計、キャピラリー式粘度計）;エンドユース（病院エンドユース、診断エンドユース、その他エンドユース）

調査対象企業の例（注目の41社）

  • A&D HOLON Holdings Co., Ltd.
  • AMETEK Inc.（Brookfield Engineering）
  • Anton Paar GmbH
  • ATAGO Co., Ltd.
  • Benson Viscometers Ltd.
  • BioFluid Technology Inc.
  • Cambridge Viscosity Inc.
  • Cannon Instrument Company
  • Fann Instrument Company
  • Grifols, S.A.
  • Haemonetics Corporation
  • Health Onvector
  • KYOTO ELECTRONICS MANUFACTURING CO., LTD.
  • LAUDA Scientific GmbH
  • Lamy Rheology
  • Microvisk Ltd.
  • PCE Instruments
  • Radiometer Medical ApS
  • RheoSense Inc.
  • Thermo Fisher Scientific Inc.

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36402

Global Blood Viscometers Market to Reach US$4.6 Billion by 2030

The global market for Blood Viscometers estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Rotational Viscometers Product, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Capillary Viscometers Product segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$938.6 Million While China is Forecast to Grow at 7.7% CAGR

The Blood Viscometers market in the U.S. is estimated at US$938.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$901.1 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Blood Viscometers Market - Key Trends & Drivers Summarized

Why Are Blood Viscometers Gaining Clinical Importance in Cardiovascular and Hemorheological Assessments?

Blood viscometers are gaining heightened clinical relevance as the healthcare community increasingly recognizes the importance of blood viscosity as a key biomarker in diagnosing and managing cardiovascular, metabolic, and hematologic conditions. Blood viscosity, or the thickness and stickiness of blood, plays a critical role in determining vascular resistance and overall circulatory efficiency. Elevated blood viscosity is linked to a range of disorders, including hypertension, atherosclerosis, diabetes, stroke, and peripheral artery disease. Consequently, clinicians are integrating viscometric assessments into routine diagnostics and risk stratification protocols, particularly for high-risk populations such as the elderly, diabetics, and patients with chronic inflammatory conditions. Unlike conventional diagnostics that often focus on cholesterol, blood pressure, or glucose levels alone, viscometers provide insight into the mechanical behavior of blood under various shear rates-offering a more holistic view of vascular health. These measurements are particularly valuable in understanding microcirculatory dysfunction and endothelial stress, which can precede major cardiovascular events. As personalized and preventive medicine gains momentum, the need for accurate, point-of-care tools like blood viscometers is intensifying. Hospitals, research institutions, and specialty clinics are increasingly adopting these devices to refine their diagnostic models and optimize treatment plans. In this evolving medical landscape, blood viscometers are emerging not just as laboratory tools but as critical enablers of precision cardiovascular care.

How Are Technological Innovations Enhancing the Accuracy and Accessibility of Blood Viscometers?

Advancements in viscometer technology are transforming these instruments into highly sophisticated and user-friendly diagnostic tools, making them more accessible for both clinical and research applications. Traditional viscometers required larger blood volumes, complex calibration, and manual operation, limiting their widespread use outside of specialized labs. Today’s blood viscometers incorporate microfluidic systems, digital sensors, and automated analysis software that significantly improve ease of use, speed, and precision. Many newer models can perform multiple shear rate measurements with a single drop of blood, offering detailed rheological profiles in real time. Innovations in thermal and mechanical stabilization have improved the reproducibility of results, while touchscreen interfaces and wireless connectivity enhance usability and data integration. These technological upgrades allow for seamless connection with electronic medical records (EMRs), enabling clinicians to monitor changes in blood viscosity over time as part of chronic disease management. Additionally, miniaturized and portable viscometers are being developed for bedside diagnostics, emergency care, and mobile health units, increasing their application scope in decentralized settings. Artificial intelligence and machine learning are also beginning to play a role, with algorithms capable of interpreting complex viscosity patterns to support early diagnosis and predictive analytics. As cost-effective and scalable solutions continue to emerge, technological innovation is pushing blood viscometers from the periphery of diagnostic testing into mainstream clinical workflows, expanding their utility across a growing range of healthcare environments.

How Are Diverse Clinical Applications Expanding Market Opportunities for Blood Viscometers?

The versatility of blood viscometers across a wide array of medical disciplines is significantly broadening their market potential. In cardiology, they are used to assess hemodynamic stress and thrombotic risk, providing vital data that can inform the use of anticoagulants and statins. In endocrinology, blood viscosity measurements help evaluate microvascular complications in patients with diabetes and metabolic syndrome. Oncologists use viscometric data to monitor hyperviscosity syndrome, which can occur in patients with certain hematologic malignancies such as multiple myeloma. In neurology, blood viscosity has shown potential in assessing stroke risk and cognitive decline, particularly among aging populations. Hematologists rely on these devices to diagnose and monitor polycythemia, anemia, and blood clotting disorders. Additionally, researchers are investigating the role of blood viscosity in inflammatory diseases, autoimmune conditions, and even infectious diseases like COVID-19, where hypercoagulability has emerged as a serious complication. Pharmaceutical companies are also using blood viscometers in clinical trials to evaluate the rheological effects of investigational drugs, particularly those targeting the vascular system. This wide range of applications is fueling demand in hospitals, diagnostic labs, academic institutions, and biotech firms. Moreover, sports medicine and wellness centers are beginning to adopt viscometers for performance monitoring and cardiovascular screening in elite athletes. As awareness of blood viscosity as a critical health metric grows, its integration into multidisciplinary care models is rapidly expanding, presenting new growth avenues for manufacturers and healthcare providers alike.

What Are the Key Drivers Behind the Growth of the Blood Viscometers Market?

The growth in the blood viscometers market is driven by a confluence of medical, technological, economic, and demographic factors that reflect the shifting priorities of modern healthcare. One of the primary drivers is the rising global burden of cardiovascular and metabolic diseases, which are prompting clinicians to seek more nuanced diagnostic tools beyond standard markers. As lifestyle diseases become more prevalent in both developed and emerging economies, there is a growing demand for early detection tools that can offer predictive insights into vascular health-something blood viscometers are uniquely positioned to deliver. Technological innovation has also made these devices more compact, affordable, and user-friendly, facilitating adoption in smaller clinics and decentralized care settings. Healthcare systems are increasingly prioritizing preventive care and value-based outcomes, both of which align with the early diagnostic capabilities of blood viscometers. Regulatory support and clinical guideline updates that emphasize comprehensive cardiovascular risk assessment are further legitimizing their role in practice. In parallel, increased investment in medical research and diagnostic infrastructure-particularly in Asia-Pacific and Latin America-is opening new markets and expanding global reach. Educational initiatives and continuing medical education (CME) programs are helping clinicians understand the significance of blood viscosity and how to interpret viscometric data, enhancing usage and trust. Lastly, the integration of viscometers with digital health platforms and data analytics tools is increasing their utility in longitudinal patient monitoring and chronic disease management. Together, these drivers are laying a strong foundation for the sustained expansion of the blood viscometers market in both clinical and commercial domains.

SCOPE OF STUDY:

The report analyzes the Blood Viscometers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Rotational Viscometers Product, Capillary Viscometers Product); End-Use (Hospitals End-Use, Diagnostics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • A&D HOLON Holdings Co., Ltd.
  • AMETEK Inc. (Brookfield Engineering)
  • Anton Paar GmbH
  • ATAGO Co., Ltd.
  • Benson Viscometers Ltd.
  • BioFluid Technology Inc.
  • Cambridge Viscosity Inc.
  • Cannon Instrument Company
  • Fann Instrument Company
  • Grifols, S.A.
  • Haemonetics Corporation
  • Health Onvector
  • KYOTO ELECTRONICS MANUFACTURING CO., LTD.
  • LAUDA Scientific GmbH
  • Lamy Rheology
  • Microvisk Ltd.
  • PCE Instruments
  • Radiometer Medical ApS
  • RheoSense Inc.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Blood Viscometers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Hemorheology in Cardiovascular Risk Assessment Throws the Spotlight on Blood Viscometers
    • Growing Adoption in Clinical Diagnostics Spurs Demand for High-Precision Blood Viscosity Measurement Devices
    • Here's How Increased Awareness of Blood Flow Disorders Is Driving Use of Viscometers in Preventive Cardiology
    • Advancements in Point-of-Care Testing Technologies Expand the Accessibility of Bedside Viscosity Monitoring
    • Integration with Electronic Health Records and Smart Lab Systems Strengthens the Business Case for Digital Viscometers
    • Aging Population and Increased Prevalence of Hypertension and Diabetes Expand the Clinical Use of Blood Viscometry
    • Here's the Story: How Oncology and Critical Care Units Are Using Blood Viscometers to Monitor Treatment Impact
    • Surge in Research on Microcirculation and Thrombosis Supports Broader Application Across Specialty Clinics
    • Miniaturization and Automation Drive Innovation in Portable and User-Friendly Blood Viscometer Devices
    • Rising Demand from Pharmaceutical and Biotech Companies for Blood Rheology Data Fuels Use in Drug Trials
    • Global Expansion of Specialty Diagnostic Labs Creates New Market Opportunities for Advanced Viscometry Platforms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Viscometers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood Viscometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Rotational Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Rotational Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Rotational Viscometers Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Capillary Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Capillary Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Capillary Viscometers Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Diagnostics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Blood Viscometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Blood Viscometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Blood Viscometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Blood Viscometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION